Pharma Industrial India - Professional magazine for pharma industry suppliers and lab technology

NEWS ABOUT >

Biotechnology

Clean Rooms

Clinical Trials

Consultants

Digitalization

Drug Discovery & Development

Engineering

Global Pharma

Industrial talks

Ingredients

Lab Equipment

Logistics & Distribution

Manufacturing

Market

Outsourcing

Packaging

Quality / GMP

Regulation

Safety

Last edition

All magazines
Subscribe to our magazine

News about "Dr Yuelei Shen"

Biocytogen Launches AI-Powered RenSuper Platform to Accelerate Therapeutic Antibody Discovery

Biocytogen unveils RenSuper, a next-generation AI-driven antibody discovery and automation platform designed to streamline therapeutic biologics development and accelerate the delivery of innovative medicines worldwide.

Dr. Yuelei Shen | 28/05/2026 | By News Bureau | 117

Biocytogen Grants Licence for RenNano Platform to Taisho Pharmaceutical

Biocytogen licenses its RenNano platform to Taisho Pharmaceutical to advance fully human heavy chain-only antibody discovery, supporting in-vivo screening and downstream research.

Dr Yuelei Shen | 31/03/2026 | By News Bureau

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members